Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

This study has been completed.
Information provided by:
Ranbaxy Inc. Identifier:
First received: October 17, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2003
  Primary Completion Date: September 2003 (Final data collection date for primary outcome measure)